Charles River Laboratories | CRL - Sales Revenues


Charles River Laboratories reported $1000M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Align Technology USD 1.02B 40M Sep/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Cardinal Health USD 63.7B 2.8B Jun/2026
Charles River Laboratories USD 1000M 4.2M Jun/2026
Cigna USD 71.7B 3.18B Jun/2026
Concord Medical Services Hldg CNY 259.9M 59.28M Dec/2025
CVS Health USD 106.1B 5.7B Jun/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 898M 18M Jun/2026
Elevance Health USD 51.43B 1.63B Sep/2026
Humana USD 40.89B 1.24B Jun/2026
Illumina USD 1.16B 70M Jun/2026
Incyte USD 1.56B 110M Sep/2026
Intrexon USD 717K 511K Jun/2024
IQVIA Holdings USD 4.43B 60M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Lakefront Biotherapeutics EUR 12.11M 5.61M Jun/2026
Lonza CHF 3.58B 63M Jun/2025
McKesson USD 105.38B 13.08B Jun/2026
Merck EUR 5.43B 300M Jun/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Novartis USD 14.52B 112M Sep/2026
Pfizer USD 15.03B 530M Jun/2026
Quest Diagnostics USD 3.1B 57M Sep/2026
Revvity USD 729.68M 18.68M Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
United Therapeutics USD 783.3M 1.8M Jun/2026
UnitedHealth USD 112.69B 694M Sep/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.64B 370M Jun/2026
West Pharmaceutical Services USD 874.5M 2.2M Sep/2026